Each group contained 75 individuals, and we analyzed the CDA activity of all the serum samples from these subjects (the analyses described below were performed on these two matched patient and control groups of 75 individuals each for the purposes of comparison, or on the 183 BC patients from the initial cohort if no comparison with controls was required) (Supplementary Table 2). The gene discussed is CDA; the disease is breast cancer.